Advancing therapeutic development through research and development of innovative assay (test) designs and chemical library screening methods. Learn more.
Drugs to Block Ebola
Research team from NCATS and the Icahn School of Medicine at Mount Sinai has identified 50+ drugs that may block infection.
Assay Development and Screening Technology
Find out more about the ADST program, its mission and goals, and its progress to date.
Access state-of-the-art expertise, tools and technologies for assay development and high-throughput screening.
Work with ADST
Learn how to collaborate with the ADST program to develop an assay or screen.
Explore the details behind current ADST program projects.
ADST in Action
A collaboration involving a patient advocacy group, pharmaceutical companies, academic researchers and ADST program experts culminated in an innovative advance in drug discovery technology, enabling the team to identify a potential new drug target for one of the most common forms of an inherited neurological disorder called Charcot-Marie-Tooth disease. See more ADST in action.